Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2643 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Arcutis’s NDA for acne drug wins FDA approval

Evaluated in clinical studies enrolling over 3,200 subjects with moderate to severe acne, Acanya Gel is said to be the only FDA-approved fixed combination antibiotic and benzoyl peroxide

Idera and Merck extend research collaboration

Idera and Merck have previously entered into an exclusive license and research collaboration agreement to research, develop and commercialize vaccine products containing the company’s investigational agonist compounds targeting

SCS signs service agreement with Pfizer

Under the terms of the agreement, Stem Cell Sciences (SCS) will provide research services, cell lines, media and reagents to support Pfizer’s R&D efforts in this important field.

Elan names new president

Dr Paya will be based at Elan’s South San Francisco campus, with particular focus on and responsibility for leading the company’s scientific, clinical and medical initiatives and delivering

BMP Sunstone acquires Runchang capsule

Sunstone will also receive the entire liquid-filled (LFHC) filling and sealing production line, as well as related LFHC technology from Darentang Pharmaceutical, which is a subsidiary of Tianjin